Somatic mutations in cancer development

Environmental Health: A Global Access Science Source

Volumn 10, Issue SUPPL. 1, 2011, Pages

  Luzzatto, Lucio ^a  

^a ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

CANCER; CYTOLOGY; GENE EXPRESSION; GENOMICS; LESION; MUTATION; PHENOTYPE; QUANTITATIVE ANALYSIS; TUMOR;

CANCER CELL; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL POPULATION; CELL TRANSFORMATION; CONFERENCE PAPER; DNA REPAIR; EXOME; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MICROARRAY ANALYSIS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC CELL; SOMATIC MUTATION; TUMOR GENE; ARTICLE; GENETICS; MUTATION; PATHOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MUTATION;

EID: 79953805967     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-10-S1-S12     Document Type: Conference Paper

References (36)

1. Nitrosoazetidine - a potent carcinogen of low toxicity. W Lijinsky KY Lee L Tomatis WH Buutler, Die Naturwissenschaften 1967 54 19 518 10.1007/BF01129377 5586158
2. Identification of carcinogenic agents and primary prevention of cancer. L Tomatis, Annals of the New York Academy of Sciences 2006 1076 1 14 10.1196/annals.1371.039 17119190 (Pubitemid 44970391)
3. The Genetic Basis of Human Cancer. BaK Vogelstein W K, New York: McGraw-Hill 2nd 2002
4. Clinical cancer genetics: risk counseling and management. K Offit, New York: Wiley-Liss 1998 1
5. Three cases of familial hairy cell leukemia. M Gramatovici JM Bennett JG Hiscock KS Grewal, American journal of hematology 1993 42 4 337 339 10.1002/ajh.2830420402 8493982 (Pubitemid 23104803)
6. Epidemiologic approaches to cancer etiology. JF Fraumeni Jr., Annual review of public health 1982 3 85 100 10.1146/annurev.pu.03.050182.000505 6293517
7. An estimate of the heritable fraction of childhood cancer. SA Narod C Stiller GM Lenoir, British Journal of Cancer 1991 63 993 999 10.1038/bjc.1991.216 2069856
8. Familiality of cancer in Utah. LA Cannon-Albright A Thomas DE Goldgar K Gholami K Rowe M Jacobsen WP McWhorter MH Skolnick, Cancer Res 1994 54 9 2378 2385 8162584 (Pubitemid 24138728)
9. The risk of cancer in twins: a report from the childhood cancer survivor study. NS Kadan-Lottick T Kawashima G Tomlinson DL Friedman Y Yasui AC Mertens LL Robison LC Strong, Pediatr Blood Cancer 2006 46 4 476 481 10.1002/pbc.20465 16078231 (Pubitemid 43334655)
10. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. JC Stephens D Briscoe SJ O'Brien, American journal of human genetics 1994 55 4 809 824 7942858 (Pubitemid 24298979)
11. Low penetrance genes associated with increased risk for breast cancer. BL Weber KL Nathanson, European Journal of Cancer 2000 36 10 1193 10.1016/S0959-8049(00)00082-4 10882856
12. Breast cancer genetics: what we know and what we need. KL Nathanson R Wooster BL Weber, Nature medicine 2001 7 5 552 556 10.1038/87876 11329055 (Pubitemid 32448321)
13. Molecular epidemiology and its current clinical use in cancer management. M Hartman EY Loy CS Ku KS Chia, The lancet oncology 2010 11 4 383 390 10.1016/S1470-2045(10)70005-X 20359664
14. Mutation selection and the natural history of cancer. J Cairns, Nature 1975 255 5505 197 200 10.1038/255197a0 1143315
15. Laukaemia: a genetic disorder of haemopoietic cells. L Luzzatto PP Pandolfi, British Medical Journal 1993 307 579 580 10.1136/bmj.307.6904.579 8401011 (Pubitemid 23255061)
16. Genetic instability and darwinian selection in tumours. DP Cahill KW Kinzler B Vogelstein C Lengauer, Trends in cell biology 1999 9 12 57 60 10.1016/S0962-8924(99)01661-X 10611684
17. Darwinian medicine: a case for cancer. M Greaves, Nature reviews 2007 7 3 213 221 17301845
18. A census of human cancer genes. PA Futreal L Coin M Marshall T Down T Hubbard R Wooster N Rahman MR Stratton, Nature reviews 2004 4 3 177 183 10.1038/nrc1299 14993899 (Pubitemid 38337497)
19. The hallmarks of cancer. D Hanahan RA Weinberg, Cell 2000 100 1 57 70 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)
20. Cancer genes and the pathways they control. B Vogelstein KW Kinzler, Nature medicine 2004 10 8 789 799 10.1038/nm1087 15286780 (Pubitemid 39070849)
21. Gene expression profiling predicts clinical outcome of breast cancer. LJ van 't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen,, et al. Nature 2002 415 6871 530 536 11823860 (Pubitemid 34130608)
22. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. XJ Ma Z Wang PD Ryan SJ Isakoff A Barmettler A Fuller B Muir G Mohapatra R Salunga JT Tuggle,, et al. Cancer cell 2004 5 6 607 616 10.1016/j.ccr.2004.05.015 15193263 (Pubitemid 38748922)
23. Predicting prostate cancer behavior using transcript profiles. PS Nelson, The Journal of urology 2004 172 5 Pt 2 28 32 discussion S33 10.1097/01.ju.0000142067.17181.68 15535439
24. Gene-expression signatures in breast cancer. C Sotiriou L Pusztai, The New England journal of medicine 2009 360 8 790 800 10.1056/NEJMra0801289 19228622
25. Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. D Cavalieri P Dolara E Mini C Luceri C Castagnini S Toti K Maciag C De Filippo S Nobili M Morganti,, et al. Oncology research 2007 16 11 535 548 10.3727/096504007783438376 18306933 (Pubitemid 351211326)
26. The Consensus Coding Sequences of Human Breast and Colorectal Cancers. T Sjoblom S Jones LD Wood DW Parsons J Lin TD Barber D Mandelker RJ Leary J Ptak N Silliman,, et al. Science 2006 314 5797 268 274 10.1126/science.1133427 16959974 (Pubitemid 44571966)
27. Recurring mutations found by sequencing an acute myeloid leukemia genome. ER Mardis L Ding DJ Dooling DE Larson MD McLellan K Chen DC Koboldt RS Fulton KD Delehaunty SD McGrath,, et al. The New England journal of medicine 2009 361 11 1058 1066 10.1056/NEJMoa0903840 19657110
28. Characterizing the cancer genome in lung adenocarcinoma. BA Weir MS Woo G Getz S Perner L Ding R Beroukhim WM Lin MA Province A Kraja LA Johnson,, et al. Nature 2007 450 7171 893 898 10.1038/nature06358 17982442 (Pubitemid 350231325)
29. The cancer genome. MR Stratton PJ Campbell PA Futreal, Nature 2009 458 7239 719 724 10.1038/nature07943 19360079
30. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. TJ Ley ER Mardis L Ding B Fulton MD McLellan K Chen D Dooling BH Dunford-Shore S McGrath M Hickenbotham,, et al. Nature 2008 456 7218 66 72 10.1038/nature07485 18987736
31. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. M Esteller, British journal of cancer 2006 94 2 179 183 10.1038/sj.bjc.6602918 16404435 (Pubitemid 43151531)
32. Towards the human cancer epigenome: a first draft of histone modifications. MF Fraga M Esteller, Cell cycle (Georgetown, Tex 2005 4 10 1377 1381 10.4161/cc.4.10.2113 16205112 (Pubitemid 41437126)
33. Epigenetics and cancer without genomic instability. ES McKenna CW Roberts, Cell cycle (Georgetown, Tex 2009 8 1 23 26 10.4161/cc.8.1.7290 19098432
34. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. DJ Araten K Nafa K Pakdeesuwan L Luzzatto, Proc Natl Acad Sci U S A 1999 96 9 5209 5214 10.1073/pnas.96.9.5209 10220445 (Pubitemid 29214562)
35. A Quantitative Measurement of the Human Somatic Mutation Rate. DJ Araten DW Golde RH Zhang HT Thaler L Gargiulo R Notaro L Luzzatto, Cancer Res 2005 65 18 8111 8117 10.1158/0008-5472.CAN-04-1198 16166284 (Pubitemid 41330573)
36. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. B Peruzzi DJ Araten R Notaro L Luzzatto, Mutation research 2010 705 1 3 10 10.1016/j.mrrev.2009.12.004 20034593